Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Ozarowice – page 2

17 clinical trials in Ozarowice, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Ozarowice at a glance
17
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

17 trials in Ozarowice

Open in trial search

Hidradenitis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Acne

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:(S)-3-(4-Acetamidophenyl)-2-Methoxypropanoic Acid
  • Sponsor:PPM Services S.A.
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:(S)-3-(4-Acetamidophenyl)-2-Methoxypropanoic Acid
  • Sponsor:PPM Services S.A.

Actinic keratosis

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tirbanibulin
  • Sponsor:Almirall S.A.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Ozarowice

What the registry says about research in the country

01 Inflammatory Skin Conditions

Extensive research focusing on hidradenitis suppurativa, evaluating multiple novel therapeutic approaches for moderate to severe cases. Studies aim to improve treatment outcomes and patient quality of life.

  • Multiple Treatment Pathways
  • Disease Management
  • Long-term Efficacy

Several parallel investigations examining different therapeutic agents including AVTX-009, izokibep, and sonelokimab.

02 Dermatological Disorders

Comprehensive studies targeting acne vulgaris and actinic keratosis, with trials evaluating both short and long-term treatment approaches using innovative topical medications.

  • Topical Treatments
  • Safety Assessments
  • Extended Duration Studies

Research includes vehicle-controlled studies and year-long safety evaluations of new therapeutic compounds.

03 Autoimmune Skin Conditions

Advanced clinical research on cutaneous lupus erythematosus and bullous pemphigoid, investigating targeted therapeutic approaches for these challenging conditions.

  • Novel Biologics
  • Disease Control
  • Remission Studies

Investigations focus on breakthrough treatments including anifrolumab and dupilumab for sustained disease management.

04 Chronic Urticaria Management

Innovative research examining treatments for chronic spontaneous urticaria, including comparative studies of established and new therapeutic options.

  • Therapeutic Equivalence
  • Treatment Response
  • Symptom Control

Studies focus on patients with inadequate response to conventional treatments, exploring alternative therapeutic approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.